相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design, synthesis and biological evaluation of novel glycosylated diphyllin derivatives as topoisomerase II inhibitors
Da-Kuo Shi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Synthesis and biological evaluation of tetracyclic thienopyridones as antibacterial and antitumor agents
Salah A. Al-Trawneh et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Identification of a Small-Molecule Inhibitor of DNA Topoisomerase II by Proteomic Profiling
Makoto Kawatani et al.
CHEMISTRY & BIOLOGY (2011)
Potency of inhibition of human DNA topoisomerase I by flavones assessed through physicochemical parameters
Rene V. Bensasson et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
7-Azaindenoisoquinolines as Topoisomerase I Inhibitors and Potential Anticancer Agents
Evgeny Kiselev et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
2-Thienyl-4-furyl-6-aryl pyridine derivatives: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study
Pritam Thapa et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents
Salah A. Al-Trawneh et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Synthesis of 2-(thienyl-2-yl or-3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship
Pritam Thapa et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines
Radha Karki et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study
Arjun Basnet et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Furanocoumarins: Novel topoisomerase I inhibitors from Ruta graveolens L.
Renuka Diwan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Targeting DNA topoisomerase II in cancer chemotherapy
John L. Nitiss
NATURE REVIEWS CANCER (2009)
A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than doxorubicin: A comparative in vivo study
Natalya M. Kogan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Topoisomerase II-drug interaction domains: Identification of substituents on etoposide that interact with the enzyme
Amy M. Wilstermann et al.
BIOCHEMISTRY (2007)
2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship
Arjun Basnet et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives
Kassoum Nacro et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Structural studies of E-coli topoisomerase III-DNA complexes reveal a novel type IA topoisomerase-DNA conformational intermediate
Anita Changela et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry:: A public health success story
Jennifer M. Nelson et al.
CLINICAL INFECTIOUS DISEASES (2007)
HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor
Natalya M. Kogan et al.
MOLECULAR CANCER THERAPEUTICS (2007)
New peptide inhibitors of type IB topoisomerases: Similarities and differences vis-a-vis inhibitors of tyrosine recombinases
David F. Fujimoto et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Evaluation of the toxic potentials of a new camptothecin anticancer agent CKD-602 on fertility and early embryonic development in rats
Moon-Koo Chung et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2006)
Stilbenoids of Kobresia nepalensis (Cyperaceae) exhibiting DNA topoisomerase II inhibition
M Yamada et al.
PHYTOCHEMISTRY (2006)
Structure of the N-terminal fragment of topoisomerase V reveals a new family of topoisomerases
B Taneja et al.
EMBO JOURNAL (2006)
Mechanochemical analysis of DNA gyrase using rotor bead tracking
J Gore et al.
NATURE (2006)
A topological view of the replicon
JB Schvartzman et al.
EMBO REPORTS (2004)
Podophyllotoxin:: distribution, sources, applications and new cytotoxic derivatives
M Gordaliza et al.
TOXICON (2004)
Activation of mitochondrial apoptotic pathway in mantle cell lymphoma:: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes
A Ferrer et al.
ONCOGENE (2004)
A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia
E Willmore et al.
BLOOD (2004)
Combining EL4-B5-based B-cell stimulation and phage display technology for the successful isolation of human anti-Scl-70 autoantibody fragments
M Weber et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Resistance genes of aminocoumarin producers:: Two type II topoisomerase genes confer resistance against coumermycin A1 and clorobiocin
E Schmutz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Dual topoisomerase I/II inhibitors in cancer therapy
WA Denny et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2003)
Homocamptothecins: potent topoisomerase I inhibitors and promising anticancer drugs
C Bailly
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2003)
Cellular roles of DNA topoisomerases: A molecular perspective
JC Wang
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Current status and perspectives in the development of camptothecins
F Zunino et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Camptothecins - A review of their chemotherapeutic potential
H Ulukan et al.
DRUGS (2002)
Shaping the metaphase chromosome: coordination of cohesion and condensation
A Losada et al.
BIOESSAYS (2001)
Leukemias related to treatment with DNA topoisomerase II inhibitors
CA Felix
MEDICAL AND PEDIATRIC ONCOLOGY (2001)
DNA topoisomerase II as the target for the anticancer drug TOP-53: Mechanistic basis for drug action
JAW Byl et al.
BIOCHEMISTRY (2001)
Tumor cell death induced by topoisomerase-targeting drugs
TK Li et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
NB-506, an indolocarbazole topoisomerase I inhibitor, binds preferentially to triplex DNA
JS Ren et al.
FEBS LETTERS (2000)
分享论文
